(CercleFinance.com) – Ipsen announces the cooptation of Pascal Touchon as an independent director on its board of directors as of October 4, following Paul Sekhri’s decision to step down on the same date in due to other professional commitments.
This appointment will be effective for the remainder of Paul Sekhri’s term of office, until the 2026 AGM. Pascal Touchon will be a member of the Appointments Committee, the Innovation and Development Committee and the Audit Committee.
Currently CEO of Atara Biotherapeutics, Pascal Touchon previously held several management positions at Novartis and Servier, and has also served on the board of directors of various biotechnology companies.
Copyright © 2023 CercleFinance.com. All rights reserved.
Did you like this article ? Share it with your friends with the buttons below.
